US-based Crown Bioscience acquires Nottingham oncology spin-out.

Crown Bioscience has acquired University of Nottingham spin-out Preclinical Oncology Services (PRECOS) for an unspecified sum. The deal will add PRECOS’ expertise in oncology pre-clinical research and development services to Crown. As a result, the California-based firm will become one of the world’s largest suppliers of oncology services with bases in the US, the EU,…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.